当前位置:首页 - 行情中心 - 华仁药业(300110) - 财务分析 - 现金流量表

华仁药业

(300110)

  

流通市值:39.32亿  总市值:39.37亿
流通股本:11.81亿   总股本:11.82亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金658,962,409.11345,066,629.451,542,501,607.361,202,423,485.29
  收到的税费返还24,482.817,976.52124,963.844,536.03
  收到其他与经营活动有关的现金14,429,701.855,997,520.19,370,211.8221,371,322.56
  经营活动现金流入小计673,416,593.77351,072,126.071,551,996,783.021,223,799,343.88
  购买商品、接受劳务支付的现金254,440,232.15132,865,034.41650,655,783.28504,976,302.51
  支付给职工以及为职工支付的现金146,423,853.3574,078,087.18325,678,898.38247,238,880.92
  支付的各项税费62,678,512.3430,014,236.63139,019,765.48114,511,925.4
  支付其他与经营活动有关的现金40,032,339.2117,439,216.44114,282,446.2271,685,420.01
  经营活动现金流出小计503,574,937.05254,396,574.661,229,636,893.36938,412,528.84
  经营活动产生的现金流量净额169,841,656.7296,675,551.41322,359,889.66285,386,815.04
二、投资活动产生的现金流量:
  收回投资收到的现金--57,119.62-
  取得投资收益收到的现金--356,758.990
  处置固定资产、无形资产和其他长期资产收回的现金净额0-29,7365,000
  处置子公司及其他营业单位收到的现金净额1,706,659.76---
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计1,706,659.76-443,614.615,000
  购建固定资产、无形资产和其他长期资产支付的现金36,065,817.6825,822,417.5424,693,910.4323,640,099.98
  取得子公司及其他营业单位支付的现金--13,673,565.613,673,565.6
  投资活动现金流出小计36,065,817.6825,822,417.5438,367,476.0337,313,665.58
  投资活动产生的现金流量净额-34,359,157.92-25,822,417.54-37,923,861.42-37,308,665.58
三、筹资活动产生的现金流量:
  取得借款收到的现金445,515,250232,105,250843,333,192.51649,933,192.51
  收到其他与筹资活动有关的现金90,000,000--0
  筹资活动现金流入小计535,515,250232,105,250843,333,192.51649,933,192.51
  偿还债务支付的现金523,883,192.51273,360,0001,129,122,580.46938,522,580.46
  分配股利、利润或偿付利息支付的现金23,263,526.0513,028,113.3383,263,935.2171,188,574.68
  其中:子公司支付给少数股东的股利、利润--4,368,430.82-
  支付其他与筹资活动有关的现金90,000,000-448,822.48489,216.5
  筹资活动现金流出小计637,146,718.56286,388,113.331,212,835,338.151,010,200,371.64
  筹资活动产生的现金流量净额-101,631,468.56-54,282,863.33-369,502,145.64-360,267,179.13
四、汇率变动对现金及现金等价物的影响5,084.85,076.51556.98246,101.39
五、现金及现金等价物净增加额33,856,115.0416,575,347.05-85,065,560.42-111,942,928.28
  加:期初现金及现金等价物余额146,799,753.82146,799,753.82231,865,314.24231,865,314.24
  期末现金及现金等价物余额180,655,868.86163,375,100.87146,799,753.82119,922,385.96
补充资料:
  净利润39,164,980.62--1,362,832,173.87-
  资产减值准备11,582,247.29-1,449,135,462.55-
  固定资产和投资性房地产折旧42,562,421.87-95,452,628.7-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧42,562,421.87-95,452,628.7-
  无形资产摊销11,103,453.9-22,447,672.93-
  长期待摊费用摊销4,460,281.28-8,574,611.88-
  处置固定资产、无形资产和其他长期资产的损失---16,471.15-
  固定资产报废损失44,149.19-136,808.23-
  财务费用21,235,172.89-54,316,994.26-
  投资损失-2,298,173.26--356,758.99-
  递延所得税-3,678,118.1--18,527,557.68-
  其中:递延所得税资产减少-2,154,897.46--15,152,735.78-
    递延所得税负债增加-1,523,220.64--3,374,821.9-
  存货的减少38,353,357.45-9,111,247.25-
  经营性应收项目的减少-31,316,744.06-172,585,288.36-
  经营性应付项目的增加38,419,574.06--108,125,784.43-
  现金的期末余额180,655,868.86-146,799,753.82-
  减:现金的期初余额146,799,753.82-231,865,314.24-
  现金及现金等价物的净增加额33,856,115.04--85,065,560.42-
公告日期2025-08-162025-04-232025-04-232024-10-29
审计意见(境内)标准无保留意见
TOP↑